A Phase I/II Study Of PI-88 In Advanced Malignancies (Phase I), And In Advanced Melanoma(Phase II)
Latest Information Update: 29 Jun 2022
At a glance
- Drugs Muparfostat (Primary)
- Indications Cancer; Malignant melanoma
- Focus Therapeutic Use
- Sponsors Cellxpert Biotechnology
- 13 Sep 2016 New trial record
- 29 Aug 2016 Status changed from active, no longer recruiting to completed.